These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
260 related articles for article (PubMed ID: 16675076)
1. Effectiveness of a hepatitis A vaccination program for migrant children in Amsterdam, The Netherlands (1992-2004). Sonder GJ; Bovée LP; Baayen TD; Coutinho RA; van den Hoek JA Vaccine; 2006 Jun; 24(23):4962-8. PubMed ID: 16675076 [TBL] [Abstract][Full Text] [Related]
2. Effect of hepatitis A vaccination programs for migrant children on the incidence of hepatitis A in The Netherlands. Suijkerbuijk AW; Lindeboom R; van Steenbergen JE; Sonder GJ; Doorduyn Y Eur J Public Health; 2009 Jun; 19(3):240-4. PubMed ID: 19174503 [TBL] [Abstract][Full Text] [Related]
3. Pharmaco-economic evaluation of targeted hepatitis A vaccination for children of ethnic minorities in Amsterdam (The Netherlands). Postma MJ; Bos JM; Beutels P; Schilthuis H; van den Hoek JA Vaccine; 2004 May; 22(15-16):1862-7. PubMed ID: 15121296 [TBL] [Abstract][Full Text] [Related]
4. [Annual epidemics of hepatitis A in four large cities related to holiday travel among immigrant children]. van Gorkom J; Leentvaar-Kuijpers A; Kool JL; Coutinho RA Ned Tijdschr Geneeskd; 1998 Aug; 142(34):1919-23. PubMed ID: 9856179 [TBL] [Abstract][Full Text] [Related]
5. [Travel advice on the prevention of infectious diseases insufficiently obtained by indigenous and non-native inhabitants of Amsterdam, the Netherlands]. Dijkshoorn H; Schilthuis HJ; van den Hoek JA; Verhoeff AP Ned Tijdschr Geneeskd; 2003 Apr; 147(14):658-62. PubMed ID: 12712650 [TBL] [Abstract][Full Text] [Related]
6. The effect of universal toddlers-only hepatitis A virus vaccination program on seropositivity rate in unvaccinated toddlers: evidence for reduced virus circulation in the community. Barkai G; Belmaker I; Givon-Lavi N; Dagan R Pediatr Infect Dis J; 2009 May; 28(5):391-3. PubMed ID: 19295466 [TBL] [Abstract][Full Text] [Related]
7. The shifting epidemiology of hepatitis A following routine childhood immunization program in Israel. Chodick G; Green MS; Heymann AD; Rosenmann L; Shalev V Prev Med; 2007 Nov; 45(5):386-91. PubMed ID: 17599401 [TBL] [Abstract][Full Text] [Related]
8. A dynamic model for assessing universal Hepatitis A vaccination in Canada. Bauch CT; Rao AS; Pham BZ; Krahn M; Gilca V; Duval B; Chen MH; Tricco AC Vaccine; 2007 Feb; 25(10):1719-26. PubMed ID: 17229493 [TBL] [Abstract][Full Text] [Related]
9. A prevalence study of hepatitis A virus infection in a migrant community: Is hepatitis A vaccine indicated? Dentinger CM; Heinrich NL; Bell BP; Fox LM; Katz DJ; Culver DH; Shapiro CN J Pediatr; 2001 May; 138(5):705-9. PubMed ID: 11343047 [TBL] [Abstract][Full Text] [Related]
10. Risk of hepatitis B for travelers: is vaccination for all travelers really necessary? Sonder GJ; van Rijckevorsel GG; van den Hoek A J Travel Med; 2009; 16(1):18-22. PubMed ID: 19192123 [TBL] [Abstract][Full Text] [Related]
11. Impact of hepatitis A vaccination on health care utilization in the United States, 1996-2004. Zhou F; Shefer A; Weinbaum C; McCauley M; Kong Y Vaccine; 2007 May; 25(18):3581-7. PubMed ID: 17306908 [TBL] [Abstract][Full Text] [Related]
12. One dose of varicella vaccine does not prevent school outbreaks: is it time for a second dose? Lopez AS; Guris D; Zimmerman L; Gladden L; Moore T; Haselow DT; Loparev VN; Schmid DS; Jumaan AO; Snow SL Pediatrics; 2006 Jun; 117(6):e1070-7. PubMed ID: 16740809 [TBL] [Abstract][Full Text] [Related]
13. Universal hepatitis A vaccination in the United States: a call for action. Lieberman JM; Word BM; Jacobs RJ; Dagan R; Marchant CD Pediatr Infect Dis J; 2008 Apr; 27(4):287-91. PubMed ID: 18316993 [TBL] [Abstract][Full Text] [Related]
14. Effectiveness of universal hepatitis A immunization of children in Minsk City, Belarus: four-year follow-up. Fisenka EG; Germanovich FA; Glinskaya IN; Lyabis OI; Rasuli AM J Viral Hepat; 2008 Oct; 15 Suppl 2():57-61. PubMed ID: 18837836 [TBL] [Abstract][Full Text] [Related]
15. Differences in hepatitis A seroprevalence among geographical regions in Turkey: a need for regional vaccination recommendations. Ceyhan M; Yildirim I; Kurt N; Uysal G; Dikici B; Ecevit C; Aydogan A; Koc A; Yasa O; Köseoğlu M; Onal K; Hacimustafaoglu M; Celebi S J Viral Hepat; 2008 Oct; 15 Suppl 2():69-72. PubMed ID: 18837839 [TBL] [Abstract][Full Text] [Related]
17. Acute hepatitis B 14 years after the implementation of universal vaccination in Italy: areas of improvement and emerging challenges. Mele A; Tosti ME; Mariano A; Pizzuti R; Ferro A; Borrini B; Zotti C; Lopalco P; Curtale F; Balocchini E; Spada E; Clin Infect Dis; 2008 Mar; 46(6):868-75. PubMed ID: 18269332 [TBL] [Abstract][Full Text] [Related]
18. Prevalence of anti-hepatitis B and anti-hepatitis A antibodies among school aged children in Western Saudi Arabia. Jaber SM Saudi Med J; 2006 Oct; 27(10):1515-22. PubMed ID: 17013474 [TBL] [Abstract][Full Text] [Related]
19. Hepatitis A and considerations regarding the cost-effectiveness of vaccination programs. Deneke MG; Arguedas MR Expert Rev Vaccines; 2003 Oct; 2(5):661-72. PubMed ID: 14711327 [TBL] [Abstract][Full Text] [Related]
20. Long-term trends in hepatitis A incidence following the inclusion of Hepatitis A vaccine in the routine nationwide immunization program. Chodick G; Heymann AD; Ashkenazi S; Kokia E; Shalev V J Viral Hepat; 2008 Oct; 15 Suppl 2():62-5. PubMed ID: 18837837 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]